Here's Why Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Is Among the Best Diabetes Stocks to Buy Under $10

Yahoo FinanceJan 6 21:45

Piper Sandler Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $11

Futu NewsDec 6, 2024 20:31 · Ratings

Amneal to Participate at Upcoming Investor Conferences

BusinesswireDec 4, 2024 21:00

Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler

Seeking AlphaDec 4, 2024 02:52

Sector Update: Health Care Stocks Advance Premarket Friday

MT NewswiresNov 22, 2024 22:13

Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved

WSJNov 22, 2024 06:05